What Happened With Edwards Lifesciences Stock?

Zinger Key Points
  • Shares of Edwards Lifesciences gain by over 8% on Tuesday, breaking above their December high.
  • The company is scheduled to report its fourth-quarter financial results in less than a week, on Feb. 6.

Edwards Lifesciences Corporation EW shares traded higher on Wednesday. The stock surged despite any company-specific news.

What To Know: Edwards Lifesciences stock rose over 8% on Wednesday, although there were no major catalysts behind the move. The stock experienced above-average volume of 9.36 million shares, compared to its average volume of 4.18 million shares.

Previously, shares had rallied from the end of October to mid-December, at which point the stock trended lower into the end of January.

Over the past week however, shares have pushed higher, soaring above the December high.

Wednesday's move comes less than a week before the company is set to post its fourth-quarter financial results, scheduled for Feb. 6. Edwards Lifesciences is estimated to report earnings of 64 cents per share and revenue of $1.49 billion.

Related Link: Inogen Gets A Shout-Out From Citron Research On X: Here's What's Happening

EW Price Action: Shares of Edwards Lifesciences were up 6.16% at $78.45 at the close of the market, according to Benzinga Pro.

Image by Myriams-Fotos from Pixabay

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!